Keyword: The Scripps Research Institute
Human-generated antibodies have provided new clues that could boost the development of a broadly protective antiviral drug and universal flu vaccine.
Scripps Research scientists found a compound related to resveratrol could lower stem cells' defense for more efficient delivery of gene therapy.
A Scripps Research team identified the GPR139 receptor as a regulator that could reduce opioids' toxic withdrawal effects.
Floyd Romesberg, the renowned Scripps Research scientist and cofounder of Synthorx, has bid the institute adieu—under "mysterious circumstances."
Scientists have identified viral changes and antibody features that could provide a possible template for HIV vaccine design.
Bay Area drug discovery company Verge Genomics has formed industry and academic alliances in neuro disorders.
BlackThorn aims to succeed in the treacherous neuro territory by using physiological measures, rather than just a qualitative clinician assessment, to better define disease populations.
The Scripps Research Institute has rolled out DataDirect Networks’ data management system across its cryo-electron microscopy research teams.
Grünenthal names a CEO, Orexigen promotes execs from within, TSRI names a COO and startup Myovant gets underway with an ex-CMO at Medivation. Plus more hirings, firings and retirings throughout the industry.